Concepedia

Heather Maecker

HM

17

Publications

7.5K

Citations

14

H-Index

1993

Active since

Affiliations

Walter and Eliza Hall Institute of Medical Research(Current)

Stanford University

Translational Research in Oncology

The University of Melbourne

Molecular Oncology (United States)

Heather Maecker is an author at Walter and Eliza Hall Institute of Medical Research specializing in medicine, cell biology, and tumor biology.

Top concepts

MedicineCell BiologyPharmacologyTumor BiologyImmunologyCancer BiologyPharmacotherapyHealthCell SignalingCancer Research

Publications per year

1993–2016

17

Publications

17

ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets

Andrew J. Souers, Erwin R. Boghaert, Scott Ackler et al. · Nature Medicine · 2013 · 2.9K citations

Thrombopoiesis, Thrombosis, Hematological Malignancy +11

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7

Ingrid E. Wertz, Saritha Kusam, Cynthia Lam et al. · Nature · 2011 · 806 citations

Protein Function, Medicine, Immune Checkpoint Inhibitor +9

MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade

Peter Ebert, Jeanne Cheung, Yagai Yang et al. · Immunity · 2016 · 714 citations · Full text

Cancer Immunosurveillance, Medicine, Receptor Tyrosine Kinase +6

Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival

Martin Schwickart, Xiaodong Huang, Jennie R. Lill et al. · Nature · 2009 · 614 citations

Deubiquitinase Usp9x, Medicine, Cancer Cell Biology +5

Inactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancer

Khaled Ali, Dalya R. Soond, Roberto Piñeiro et al. · Nature · 2014 · 529 citations · Full text

Cancer Immunosurveillance, T-regulatory Cell, Immunology +9

Rows per page

1–5 of 17